Zdravotníctvo

Kombinace léčby INTEGRILINem (R) s rt-PA je účinná pro otevření zablokovaných tepen u pacientů s infarktem myokardu

BARCELONA (Španělsko) 1. září (PROTEXT/ots-PRNewswire) - Účinek INTEGRILINu je srovnatelný s primární cévní plastikou. Výsledky 2. fáze studie provedené na pacientech s infarktem ukazují, že INTEGRILIN (R) (eptifibatide), inhibitor krevních destiček...

Zadavatel:

Abbott Announces Approval of Breakthrough Prevention for

RSV in Europe / Synagis(TM) now available in Europe ABBOTT PARK, Ill., and GAITHERSBURG, Md. (PROTEXT) - AbbottLaboratories and MedImmune, Inc. today announced the EuropeanCommission granted a marketing authorization for Synagis(TM)(palivizumab) for...

Zadavatel:

Kendle Acquires UK Contract Research Organization /

Specialist Monitoring Services (SMS) CINCINNATI (PROTEXT) - Kendle International Inc., (Nasdaq:KNDL), a leading full-service clinical development organizationheadquartered in Cincinnati, Ohio announced today the acquisitionof Specialist Monitoring Services...

Zadavatel:

Aspect Medical Systems, Inc. Announces Filing of

Registration Statement NATICK, Mass. (PROTEXT) - Aspect Medical Systems, Inc. todayannounced that it has filed a registration statement with theSecurities and Exchange Commission for an initial public offeringof shares of its Common Stock. The shares...

Zadavatel:

Drager Medizintechnik GmbH and Masimo Corporation

Announce Pulse Oximetry Purchasing and Licensing Agreement IRVINE, Calif. (PROTEXT) - Drager Medizintechnik GmbH (Lübek,Germany) and Masimo Corporation (Irvine, CA) announced apurchasing and licensing agreement under which Drager willintegrate Masimo...

Zadavatel:

Panevropská studie regionálních rozdílů v léčbě

kardiovaskulárních chorob BARCELONA 30. srpna (PROTEXT/ost-PRNewswire) - Ze studieENACT (The European Network for Acute Coronary Treatment Study;Studie Evropské sítě pro akutní koronární léčbu) vyplývá, že pocelé Evropě byl zaznamenán vyšší výskyt nestabilní...

Zadavatel:

Akutní koronární syndrom (ACS)

BARCELONA 26. srpna (PROTEXT/ots) - Akutní koronární syndrom(ACS) je v celosvětovém měřítku hlavní příčinou úmrtí, jež neseodpovědnost za 21 procent globální úmrtnosti. V uplynulých letechvýskyt infarktu myokardu v západních státech poklesl díkyrozsáhlejšímu...

Zadavatel:

Honey Researchers to Discuss Honey's Role in Medicine

and Functional Foods / Honey in the Medicine Cabinet! LONGMONT, Colo. (PROTEXT) - Scientists will meet to discussthe future of the beekeeping industry at Apimondia'99, anInternational Congress to be held in Vancouver, BC, September 12-18, 1999....

Zadavatel:

SICOR Announces Resolution of Warning Letter From the

FDA and ANDA Approval For Vecuronium Bromide for Injection Irvine, Calif. (PROTEXT) - SICOR Inc. (Nasdaq: SCRI) todayannounced that its wholly owned subsidiary, Gensia SicorPharmaceuticals, Inc., has resolved all outstanding concernsraised by the Food...

Zadavatel:

Roche Announces Canadian Regulatory Approval of

Herceptin(R) Basel, Switzerland (PROTEXT) - Revolutionary Treatment Shownto Increase Survival in Advanced Breast Cancer Patients. The Canadian regulatory authorities granted marketing approvalfor Herceptin, Roche's novel treatment for metastatic,...

Zadavatel:

LeukoSite, ILEX Oncology and Schering AG Sign CAMPATH(R)

Agreement Cambridge, Mass.; San Antonio and Berlin (PROTEXT) -LeukoSite, Inc. (Nasdaq: LKST), ILEX(TM) Oncology, Inc. (Nasdaq:ILXO) and Schering AG, (Dax: SCHG) today announced that they haveentered into a distribution and development agreement whichgrants...

Zadavatel:

Aplikace Visudynu získala od FDA prioritní status

ATLANTA/VANCOUVER 24. srpna(PROTEXT/ots) - Společnost CIBAVision Corporation, divize oční péče společnosti Novartis AG, aPhotoTherapeutics Inc. (Nasdaq: QLTI) dnes oznámily, že americkýfederální Úřad pro potraviny a léky (FDA) přiznal prioritnístatus...

Zadavatel:

Aspect Medical Reports Sole-Source Supplier Contract

With Novation / Bispectral Index Available for Member Hospitals,Which Perform 33 Percent of All U.S. Surgeries Natick, Mass. (PROTEXT) - Aspect Medical Systems, Inc. hassigned a three-year exclusive contract to supply BispectralIndex(R) (BIS(R)) monitors...

Zadavatel:

Záchrana života - sdělení společnosti Naturprodukt CZ

PRAHA 24. srpna (PROTEXT) - S houbařskou sezónou se otevíráotázka možnosti přežití při otravách muchomůrkami. V dovoznímplánu společnosti Naturprodukt je lék Legalon SIL inj. sicc.,suchá suspenze pro přípravu infúze. Přípravek zabezpečuje ochranupřed...

Zadavatel:

Chiron Announces Phase III Clinical Trial Evaluating

Proleukin(R) In Combination With HIV Therapy Emeryville, Calif. (ots-PRNewswire) - Trial to Establish theRole of Proleukin(R) in Delaying the Progression Of AIDS in HIV-Infected Patients. Chiron Corporation (Nasdaq: CHIR) announced today that it isenrolling...

Zadavatel:

Studies Evaluate Safety and Efficacy of Bayer's

Kogenate Product Line / Studies Presented at the XVII Congress ofthe International Society of Thrombosis and Hemostasis Washington (PROTEXT) - Results were announced today from twoclinical trials presented at the International Society ofThrombosis and...

Zadavatel:

Klinické zkoušky ukázaly účinnost léku proti

Alzheimerově nemoci VANCOUVER 17. srpna (PROTEXT/ots) - Kontrolovaná klinickástudie potvrzuje, že ARICEPT zlepšuje celkovou funkci, poznávánía činnosti denního života o jeden rok. Výsledky studie, hodnotící pacienty s mírnou až mírně těžkouAlzheimerovou...

Zadavatel:

CIBA Vision and QLT Announce Regulatory Submission

Seeking Approval Of Visudyne Therapy for Wet AMD in the UnitedStates Atlanta, and Vancouver, Canada (PROTEXT) - CIBA VisionCorporation, the eye care unit of Novartis AG, and QLTPhotoTherapeutics Inc. (Nasdaq: QLTI) today announced thesubmission of a...

Zadavatel:

FEI Company Closes Micrion Merger

Hillsboro, Ore. (PROTEXT) - FEI Company (Nasdaq: FEIC) today announced the closing of its merger with Micrion Corporation, a leading developer and provider of focused ion beam (FIB) systems for semiconductor mask repair and device edit applications. Massachusetts-based...

Zadavatel:

EU Cites Hemispherx Patents as Precedent and Dominant 'Art' in Novel Hepatitis Treatments

Philadelphia (PROTEXT) - Hemispherx Biopharma, Inc. (Amex: HEB) today said its patents that are designated as novel treatments of hepatitis B and C have recently been singled out by the European patent office as a dominant "art" against these diseases. ...

Zadavatel: